With the introduction of the new Horizon 2020 Work Programme 2018-2020, the SME Instrument funding scheme has undergone several important changes. In this article you will learn what is new.
Food security is one of the global challenges which affects us all. According to the World Bank our food demand is projected to rise by at least 20 percent globally over the next 15 years.
Gaeu consulting skrev eu-ansökan som gav ilya pharma 30 miljoner kronor från horizon 2020 sme-instrumentet
30 miljoner kronor i Fas 2-bidrag inom Horizon 2020 SME-instrumentet blev resultatet från ett samarbete mellan EU-bidragskonsulten GAEU Consulting och forskningsbolaget Ilya Pharma.
I gott samarbete med SymCel skrev GAEU först en beviljad Fas 1-ansökan
A biopharmaceutical, also known as a biologic(al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi-synthesised from biological sources.
The SME Instrument is a highly competitive programme with a limited budget. Convincing the experts evaluators about your idea is a very demanding task (only a few percent of projects receive a grant)
This is the perfect time to apply for funding for the development of orphan therapies. In this article you will learn about orphan drugs and where to find EU grants to finance research that specifically targets treatment of rare diseases.
Even if the SME Instrument application only resulted in a Seal of Excellence (SoE) it is important to remember the following. As long as there is a true innovative core and a significant business potential in the project, there is a variety...
Planets, stars and galaxies have always fascinated human imagination but only recent generations can boast about living in the Age of Space.
The impact of innovation is visible in many aspects of life – but what ensures that innovative ideas can become realities? Funding.
“We are leaving the European Union, but we are not leaving Europe - and we want to remain committed partners and allies to our friends across the continent.” – Theresa May.